|
Report Date : |
29.12.2014 |
IDENTIFICATION DETAILS
|
Name : |
KEMIKO PHARMACEUTICALS LIMITED |
|
|
|
|
Formerly Known As : |
KEMIKO LABORATORIES LTD |
|
|
|
|
Registered Office : |
338, Segun Bagicha, Dhaka-1000, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
28.04.1986 |
|
|
|
|
Com. Reg. No.: |
C-15516 |
|
|
|
|
Legal Form : |
Private Company |
|
|
|
|
Line of Business : |
Manufacturer of Tablet, Capsule, Syrup, Powder for Suspension,
Injection, Cream, Ointment |
|
|
|
|
No. of Employees : |
2500 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Bangladesh's economy has
grown roughly 6% per year since 1996 despite political instability, poor
infrastructure, corruption, insufficient power supplies, slow implementation of
economic reforms, and the 2008-09 global financial crisis and recession.
Although more than half of GDP is generated through the service sector, almost
half of Bangladeshis are employed in the agriculture sector with rice as the
single-most-important product. Garment exports, the backbone of Bangladesh’s
industrial sector and 80% of total exports, surpassed $21 billion last year,
18% of GDP. The sector has remained resilient in recent years amidst a series
of factory accidents that have killed over 1,000 workers and crippling strikes
that shut down virtually all economic activity. Steady garment export growth
combined with remittances from overseas Bangladeshis, which totaled almost $15
billion and 13% of GDP IN 2013, are the largest contributors to Bangladesh’s
current account surplus and record foreign exchange holdings
|
Source
: CIA |
|
Correct company Name |
: |
Kemiko
Pharmaceuticals Limited |
|
Previous name |
: |
Kemiko
Laboratories Ltd |
|
Head Office |
: |
338, Segun Bagicha, Dhaka-1000, Bangladesh. |
|
Tel No |
: |
880-2-8313561,
9347725, 01534578996 |
|
Fax No |
: |
88-02-9340085 |
|
E-mail |
: |
corporate@kemikopharma.com,
hrd@kemikopharma.com |
|
Website |
: |
www.kemikopharma.com |
|
Date/ Year of Incorporation |
: |
28.04.1986 |
|
Incorporation
No. |
: |
C-15516 |
|
Legal Form (General) |
: |
Public Listed Co Public (but not listed) Private Co
State-owned Co Sole Proprietorships Partnership Not Registered others (please specify) ________________ |
|
Legal form (Specific) |
: |
LTD
CORP
INC CO
others (please specify) ________________ |
|
Issuing Authority |
: |
Registrar
of Joint Stock Companies & Firms
City Corporation Municipal Administration Union Council Cantonment Board Chief Controller of Import & Export (CCIE) |
|
|
|||
|
Year |
Turnover/ Sales |
Assets |
Income |
|
July’ 12~June’ 13 |
BDT 410 Million |
BDT 25.00 Million |
BDT 42.21 Million |
|
July’ 13~June’ 14 |
BDT 489 Million |
BDT 36.85 Million |
BDT 29.82 Million |
|
Exchange Rate |
USD1-Tk. 77.8200 EUR 1- Tk. 100.2711 GBP 1- Tk.118.5354 AUD 1 - Tk.82.8563 JPY 1 - Tk.0.9286 |
CAD 1 - Tk.80.1887 SEK 1 - Tk.12.2870 SGD 1 - Tk.65.3045 CNH 1 - Tk.12.8399 |
|
|
Information Parted By |
||
|
|
|
|
|
Name |
: |
Mr. Saifur
Rahman. |
|
Designation |
: |
Senior Executive |
|
Contract No |
: |
N/A |
|
Locations Details |
||
|
|
||
|
Operating Address |
: |
338, Segun Bagicha, Dhaka-1000, Bangladesh. |
|
Tel No |
: |
880-2-8313561,
9347725, 01534578996 |
|
Fax No |
: |
88-02-9340085 |
|
E-mail |
: |
corporate@kemikopharma.com,
hrd@kemikopharma.com |
|
Website |
: |
www.kemikopharma.com |
|
Location : |
: Owned |
Ö |
|
Rented |
|
|
Leased |
|
Area |
3200 |
Sq. ft. |
|
Type of Office : |
: Commercial Office Bldg. |
Ö |
|
Semi-commercial office Bldg. |
|
|
|
|
Retail shop |
|
|
Industrial Park |
|
|
|
|
Business Center |
|
|
Home Office |
|
|
|
|
Residential Bldg. |
|
|
|
|
|
|
|
Factory: |
|
|
|
|
|
|
|
Address |
: |
Tikapara,
Ghoramara, Rajshahi, Bangladesh. |
|
Tel No |
: |
880-721-774469,
774214 |
|
Fax No |
: |
880-721-
774469 |
|
Owned |
Ö |
|
Rented |
|
|
Leased |
|
Area |
62800 |
Sq. ft. |
|
Branch-1: |
|
|
|
|
|
|
|
Address |
: |
Sultan masion,
21, Panchalaish, Chittagong, Bangladesh. |
|
Tel No |
: |
Nil |
|
Fax No |
: |
Nil |
|
Branch-2: |
|
|
|
|
|
|
|
Address |
: |
150, Kajal
Shah R/A, Nawab Road, Sylhet, Bangladesh. |
|
Tel No |
: |
Nil |
|
Fax No |
: |
Nil |
|
Branch-3: |
|
|
|
|
|
|
|
Address |
: |
‘Ashray’
110/102 (Ground Floor), Bagichgaon, Comilla, Bangladesh. |
|
Tel No |
: |
Nil |
|
Fax No |
: |
Nil |
|
Branch-4: |
|
|
|
|
|
|
|
Address |
: |
House# 32,
Road3 10, Dhap Eng. Para, Burir Ha Road, Rangpur, Bangladesh. |
|
Tel No |
: |
Nil |
|
Fax No |
: |
Nil |
|
Employee: |
|
|||||||
|
|
|
|||||||
|
No. of Employees |
In Office |
: |
200 |
In Factory |
: |
2300 |
||
|
In Branch: |
: |
- |
Total |
: |
2500 |
|||
|
Details: |
|
|
|
|||||
|
Names of Shareholders |
No. of Share |
|
Mr. M.A. Kalam |
400500 |
|
Mr. M.S.Jalal |
100 |
|
Grand Holdings Ltd |
20000 |
|
Mr. Md. Abul Monsuir |
50 |
|
Mr. Md. Abdul Wahab |
50 |
|
Mrs. Nurul Akhter Aurora |
11000 |
|
Mr. Md. Nurul Kalam aswad |
7120 |
|
Name |
Designation |
|
Mr. M.A. Kalam |
Chairman |
|
Mrs. Nurul Akhter Aurora |
Managing
Director |
|
Mr. M. S. Jalal |
Director |
|
Mr. Md. Abul Monsuir |
Director |
|
Mr. Md. Abdul Wahab |
Director |
|
Mr. Md. Nurul Kalam aswad |
Director |
|
Name |
: |
Mr. Saifur
Rahman |
|
Job Description |
: |
Senior
Executive |
|
Nationality |
: |
Bangladeshi |
|
Email address |
: |
N/A |
|
Other details |
: |
N/A |
|
|
|
|
|
Nature of
Activity : |
Manufacturer |
Ö |
Trader |
|
Dealer |
|
Distributor |
Ö |
|
|
|
|||||||
|
|
Exporter |
|
Importer |
|
Services |
|
Others |
|
|
Item Dealings In: |
||
|
|
||
|
Products |
: |
Tablet, Capsule, Syrup, Powder for Suspension, Injection, Cream, Ointment |
|
Production Capacity |
: |
N/A |
|
Last Year
Production |
: |
N/A |
Trading Terms:
|
Purchasing Terms: |
L/C |
Ö |
Cash |
|
Others |
|
|
|||
|
|
Credit : |
|
30 days |
|
60 days |
Ö |
90 days |
|
|
days |
|
Selling Terms : |
L/C |
|
Cash |
Ö |
Others |
|
|
|||
|
|
Credit : |
Ö |
30 days |
|
60 days |
|
90 days |
|
|
days |
|
Trade Reference
& Related Parties |
: |
Overseas Clients |
: |
N/A |
Local Clients |
: |
N/A |
|
|||
|
Overseas Suppliers |
: |
N/A |
Local Suppliers |
: |
N/A |
|
|||||
|
Trade Markets |
: |
Exports |
: |
N/A |
|
||||||
|
Imports |
: |
China, India, Korea, Japan, Turkey, Etc. |
|
||||||||
|
|
|
||||||||||
|
Brand Name |
: |
N/A |
|||||||||
|
Certified |
: |
ISO 9001:2008 |
|||||||||
|
Auditors |
: |
N/A |
|||||||||
|
Operation Status |
: |
Active |
|||||||||
|
Member |
: |
N/A |
|||||||||
|
|
|
||||||||
|
Authorized Capital |
: |
BDT 100 Million |
|
||||||
|
Paid-up Capital |
: |
BDT 4, 38,82,000 |
No. of Shares |
: |
4, 38,820 |
Share Value |
: |
BDT100.00Each |
|
|
Main Assets |
: |
BDT 36.85 Million |
|
||||||
|
The subject company don’t submit update full financial
figure to local registry office. |
|
Sister Concerns |
: |
Nil |
|
Subsidiary |
: |
N/A |
|
Name of
The Group |
: |
Nil |
|
Bank Name |
: |
Pubali Bank
Ltd. |
|
Bank Address |
: |
B.B. Avenue
Branch. 65, B.B.
Avenue, Dhaka-1000 Bangladesh. 880 2 9550600
880 2 9555406 |
|
Dishonored
Checks |
:
|
No Record
Found |
|
Debt |
: |
No Record
Found |
|
Litigation |
: |
Clear |
|
Performance
Defaults |
: |
No Record
Found |
|
Adverse Local Media
Coverage/ Adverse Filling History |
: |
No Record
Found |
|
Our Representative Visited the subject company Head office which is situated at 338, Segun Bagicha, Dhaka-1000, Bangladesh. Its office is situated at commercial area which is a well decorated modern office. |
|
SC is considered medium-sized in its line with fairly stable financial conditions. A credit line up to USD 1, 00,000 would appear to be within SC’s capacities. |
|
Adopted
Abbreviations: |
|||
|
NA- Not
Available |
TK- Bangladeshi Taka |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.64 |
|
|
1 |
Rs.98.98 |
|
Euro |
1 |
Rs.77.74 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.